Skip to main content
A Systematic Comparison of Implementation Strategies at Three U.S. Clinic Settings That Expanded Access to Self-administered Injectable Contraception
Published Web Location
https://www.sciencedirect.com/science/article/pii/S0010782425001635?via%3DihubNo data is associated with this publication.
Abstract
(Abstracted from Contraception 2025;149:110972) In the United States, depot medroxyprogesterone acetate (DMPA) is distributed in the subcutaneous (SC) formulation in prefilled, single-dose syringes; this format makes self-administration or administration by someone other than a clinician easy and accessible. This may improve contraceptive access by making the medication more available and not requiring a clinician visit for its administration.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.